Partnerships

Mogrify is looking to partner with disruptive innovators in the fields of regenerative medicine, in vivo reprogramming and ex vivo cell therapy to develop treatments for indications of high unmet clinical need. We are particularly interested in speaking with those with interest in ophthalmology, otology and metabolic, as well as other areas of degenerative disease where these modalities may be of interest. Mogrify is commercializing its technology via a combination of internal therapy development and co-development partnerships, as well as the exploitation of the platform in other therapeutic and non-therapeutic applications.